Medical Therapies to Conquer Surgical Diseases: Gallstone Disease May Be the Next Frontier
Open Access
- 1 January 2024
- journal article
- editorial
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 17, 21-27
Abstract
Over the past half century, diseases that were predominantly treated surgically have transitioned to less invasive medical therapies. Such diseases that are now effectively treated with medicine are (1) peptic ulcer disease (PUD), (2) coronary artery disease (CAD), and (3) gastrointestinal stromal tumors (GISTs). Likewise, gallstone disease may soon follow this trend. Currently, the gold standard treatment of symptomatic gallstones is laparoscopic cholecystectomies. Though one of the most common surgeries in the United States, certain cases of acute and gangrenous cholecystitis can be some of the most difficult surgeries to perform. Advancements in neutrophil extracellular trap (NET) inhibitor medical therapies will alter gallstone disease management and the mainstream role of surgical interventions. This focus on less invasive therapies will greatly impact the quality of patient care, financial obligations, and even resident training opportunities.Keywords
This publication has 30 references indexed in Scilit:
- Gastrointestinal Stromal TumorsAdvances in Surgery, 2014
- Statins: Past and PresentHeart Views, 2011
- Downsizing Treatment with Tyrosine Kinase Inhibitors in Patients with Advanced Gastrointestinal Stromal Tumors Improved ResectabilityWorld Journal of Surgery, 2010
- Surgical outcomes of open cholecystectomy in the laparoscopic eraThe American Journal of Surgery, 2009
- Statin Cost-Effectiveness in the United States for People at Different Vascular Risk LevelsCirculation: Cardiovascular Quality and Outcomes, 2009
- Improved Postoperative Outcomes Associated with Preoperative Statin TherapyAnesthesiology, 2006
- Surgery for gastrointestinal stromal tumour in the post‐imatinib eraAnz Journal of Surgery, 2005
- Admission rates for peptic ulcer in the Trent Region, UK, 1972–2000Digestive and Liver Disease, 2004
- The History of Surgery for Ischemic Heart DiseaseThe Annals of Thoracic Surgery, 1997
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994